Zusammenfassung
Herz- und Kreislauferkrankungen sind die häufigsten Todesursachen in Deutschland. Da das Alter für die meisten Herz- und Kreislauferkrankungen ein eigenständiger und unabhängiger Risikofaktor ist, sind alte Menschen hiervon besonders betroffen, wobei das Risiko mit steigendem Lebensalter sogar exponentiell ansteigt. Dies gilt v. a. für den Bluthochdruck, der wiederum der wichtigste Risikofaktor für die koronare Herzkrankheit (KHK; Herzkranzgefäßerkrankung), die Herzinsuffizienz (Herzschwäche) sowie den Schlaganfall ist. Ein weiterer Risikofaktor ist der Diabetes mellitus, der insbesondere das Risiko für die Entwicklung einer Herzinsuffizienz erhöht, aber auch für die anderen genannten Krankheiten von Bedeutung ist. Herzinsuffiziente Patienten wiederum haben eine höhere Wahrscheinlichkeit, Diabetes zu entwickeln.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsLiteratur
Aggarwal NT, Wilson RS et al (2014) Perceived stress and change in cognitive function among adults 65 years and older. Psychosom Med 76(1):80–85
van Agtmaal MJM, Houben A et al (2017) Association of microvascular dysfunction with late-life depression: a systematic review and meta-analysis. JAMA Psychiat 74(7):729–739
Bartl, R. (2006) Blickpunkt Ernährung – folgenreiches Fehlverhalten von Jung bis Alt https://www.osd-ev.org/osteoporose/bni/blickpunkt-ernaehrung/
Bauer JM (2016) Sarkopenie und Frailty 2016. Z Gerontol Geriat 49:565–566
Bellou V, Belbasis L et al (2017) Systematic evaluation of the associations between environmental risk factors and dementia: an umbrella review of systematic reviews and meta-analyses. Alzheimers Dement 13(4):406–418
Bennett DA, Wilson RS et al (2013) Selected findings from the religious orders study and rush memory and aging project. J Alzheimers Dis 33(Suppl 1):S397–S403
Brummett BH, Austin SB et al (2013) Long-term impact of caregiving and metabolic syndrome with perceived decline in cognitive function 8 Years later: a pilot study suggesting important avenues for future research. Open J Med Psychol 2(1):23–28
Chang KP et al (2004) Incidence of hip and other osteoporotic fractures in elderly men and women: dubbo osteoporosis. J Bone Miner 19(4):532–536
Chien LY, Chu H et al (2011) Caregiver support groups in patients with dementia: a meta-analysis. Int J Geriatr Psychiatry 26(10):1089–1098
Collard RM, Arts M, Comijs HC et al (2015) The role of frailty in the association between depression and somatic comorbidity: results from baseline data of an ongoing prospective cohort study. Int J Nurs Stud 52:188–196
Delbaere K et al (2010) Determinant of disparities between perceived and physiological risk of falling among elderly people: cohort study. BMJ 341:c4165. https://doi.org/10.1136/bmj
Dennison EM, Sayer AA, Cooper C (2017) Epidemiology of sarcopenia and insight into possible therapeutic targets. Nat Rev Rheumatol 13:340–347
Deutscher Gesundheitsbericht Diabetes 2018 und 2019
Edmonds S et al (2017) Understanding preferences for osteoporosis information to develop an osteoporosis patient education brochure. Perm J 21:16–24
Epidemiology Study (2004) J Bone Miner Res 19:532–536
Erickson KI, Voss MW et al (2011) Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci USA 108(7):3017–3022
Feeney, J., M. O’Sullivan, et al. (2018). Change in perceived stress and 2-year change in cognitive function among older adults: the irish longitudinal study on ageing. Stress Health 34(3):403–410
Fellgiebel A, Hautzinger M (Hrsg) (2017) Altersdepression: ein interdisziplinäres Handbuch. Springer, Berlin
Forbes SC, Holroyd-Leduc JM et al (2015) Effect of nutrients, dietary supplements and vitamins on cognition: a systematic review and meta-analysis of randomized controlled trials. Can Geriatr J 18(4):231–245
Fried LP et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3):M146–M156
Fuchs J et al (2016) Prävalenz von körperlicher Gebrechlichkeit (Frailty). In: Robert Koch Institut (Hrsg) Faktenblatt zu DEGS1: Studie zur Gesundheit Erwachsener in Deutschland (2008–2011). RKI, Berlin. (www.DEGS-Studie.de)
Gilbody S, Lewis H et al (2017) Effect of collaborative care vs usual care on depressive symptoms in older adults with subthreshold depression: the CASPER randomized clinical trial. JAMA 317(7):728–737
von Haehling S, Morley JE, Anker SD (2010) An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle 1:129–133
Hall CB, Lipton RB et al (2009) Cognitive activities delay onset of memory decline in persons who develop dementia. Neurology 73(5):356–361
Hardman RJ, Kennedy G et al (2016) Adherence to a mediterranean-style diet and effects on cognition in adults: a qualitative evaluation and systematic review of longitudinal and prospective trials. Front Nutr 3:22
Hautzinger M, Dykierek P et al (2017) Psychotherapeutic approaches for treatment of the elderly. Nervenarzt 88(11):1213–1220
Head D, Bugg JM et al (2012) Exercise engagement as a moderator of the effects of APOE genotype on amyloid deposition. Arch Neurol 69(5):636–643
Kirkendall DT, Garrett WE (1998) The effects of aging and training on skeletal muscle. Am J Sports Med 26:598–602
Klotz T (2002) Urologe [A] 41:315. https://doi.org/10.1007/s00120-002-0210-6
Langa KM, Larson EB et al (2017) A Comparison of the prevalence of dementia in the United States in 2000 and 2012. JAMA Intern Med 177(1):51–58
Lazarov O, Robinson J et al (2005) Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 120(5):701–713
Leitlinie des Dachverbandes der Deutschsprachigen Wissenschaftlichen Osteologischen Gesellschaften e. V. 2017
Linnemann A, Fellgiebel A (2017) Psychotherapy with mild cognitive impairment and dementia. Nervenarzt 88(11):1240–1245
Livingston G, Sommerlad A et al (2017) Dementia prevention, intervention, and care. Lancet 390(10113):2673–2734
Meng XF, Yu JT et al (2014) Midlife vascular risk factors and the risk of Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis 42(4):1295–1310
Moon B, Kim S et al (2017) Depressive symptoms are associated with progression to dementia in patients with amyloid-positive mild cognitive impairment. J Alzheimers Dis 58(4):1255–1264
Morley JE, Vellas B, van Kann GA, Anker SD, Bauer JM, Bernabei R, Cedari M, Chumela WC, Doehner W, Evans J, Friedl LP, Guralnik JM, Katz PR, Mamstrom TK, McCarter RJ, Gutierrez Robledo LM, Rockwood K, von Haehling S, Vandewoude MF, Walston J (2013) Frailty consensus: a call to action. J Am Med Dir Assoc 214:392–397
Nationale Versorgungs Leitlinie Prävention und Therapie von Netzhautkomplikationen bei Diabetes, 2. Aufl., Version 2, 2015, AWMF-Registernummer: nvl-001b
Neuropathology Group. Medical Research Council Cognitive Function and Aging Study (2001) Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 357(9251):169–175
Nordberg A, Carter SF et al (2013) A European multicentre PET study of fibrillar amyloid in Alzheimer’s disease. Eur J Nucl Med Mol Imaging 40(1):104–114
Phillips P (1986) Grip strenght, mental performance and nutritional status as indicators of mortality risk among female geriatric patients. Age Ageing 15:53–56
Reuben D et al (2017) The Strategies to reduce injuries and develop confidence in elders intervention: falls risk factor assessment and management, patient engagement, and nurse co-management. American Geriatrics Society 65:2733–2739
Ritt M, Gassmann KG, Sieber CC (2016) Significance of frailty für predicting adveres clinical outcomes in different patient groups with specific medical conditions. Z Gerontol Geriatr 49:567–572
Rosenberg ICH (1997) Sarcopenia: origins and clinicla relevance. J Nutr 127(5 Suppl):990s–991s
Ruscheweyh R, Willemer C et al (2011) Physical activity and memory functions: an interventional study. Neurobiol Aging 32(7):1304–1319
Russell-Williams J, Jaroudi W et al (2018) Mindfulness and meditation: treating cognitive impairment and reducing stress in dementia. Rev Neurosci
Sahni S et al (2017) Dairy intake is protective against bone loss in older Vitamin D supplement users: the framingham study. J Nutr 147:645–652
Schlosser M et al (2017) Nephropathie bei Diabetes. Diabetologie 12(Suppl 2):115–120
Schoene D et al (2017) Sklettmuskuläre Faktoren, Sarkopenie und Stürze im Alter. Z Gerontol Geriat. https://doi.org/10.1007/s00391-017-1283-6
Singh-Manoux A, Dugravot A et al (2017) Trajectories of depressive symptoms before diagnosis of dementia: a 28-Year follow-up study. JAMA Psychiatry 74(7):712–718
Smith PJ, Blumenthal JA et al (2010) Aerobic exercise and neurocognitive performance: a meta-analytic review of randomized controlled trials. Psychosom Med 72(3):239–252
Sofi F, Valecchi D et al (2011) Physical activity and risk of cognitive decline: a meta-analysis of prospective studies. J Intern Med 269(1):107–117
Spira D (2013) Dissertation Charite. Untersuchungen zum Zusammenhang zwischen Vitamin D-Mangel, Sarkopenie und Frailty-Syndrom am Beispiel einer Stichprobe in BASE-II. Berliner Altersstudie 2
Srivastava M et al (2002) Osteoporosis in elderly: prevention and treatment. Clin Geriatr Med 18:529–555
Stern Y (2009) Cognitive reserve. Neuropsychologia 47(10):2015–2028
Sternberg SA, Wershof SA, Karunananthan S, Bergman H, Mark CA (2011) The identification of frailty: a systematic literature review. J Am Geriatr Soc 59:2129–2138
Sun X, Steffens DC et al (2008) Amyloid-associated depression: a prodromal depression of Alzheimer disease? Arch Gen Psychiatry 65(5):542–550
Teipel S, Drzezga A et al (2015) Multimodal imaging in Alzheimer’s disease: validity and usefulness for early detection. Lancet Neurol 14(10):1037–1053
Valls-Pedret C, Sala-Vila A et al (2015) Mediterranean diet and age-related cognitive decline: a randomized clinical trial. JAMA Intern Med 175(7):1094–1103
Van Orden K, Deming C (2017) Late-life suicide prevention strategies: current status and future directions. Curr Opin Psychol 22:79–83
Vaughan L, Corbin AL et al (2015) Depression and frailty in later life: a systematic review. Clin Interv Aging 10:1947–1958
Vetter C (2010) Sturzneigung älterer Menschen: die Angst vor Stürzen erhöht das Risiko zu fallen. Dtsch Arztebl 107(46):A-2289/B-1979/C-1943
Wirth M, Villeneuve S et al (2014) Gene-environment interactions: lifetime cognitive activity, APOE genotype, and beta-amyloid burden. J Neurosci 34(25):8612–8617
Wolf D, Fischer FU et al (2014) Structural integrity of the corpus callosum predicts long-term transfer of fluid intelligence-related training gains in normal aging. Hum Brain Mapp 35(1):309–318
Wong SYS, Sun YY et al (2018) Treating subthreshold depression in primary care: a randomized controlled trial of behavioral activation with mindfulness. Ann Fam Med 16(2):111–119
Wu YT, Fratiglioni L et al (2016) Dementia in western Europe: epidemiological evidence and implications for policy making. Lancet Neurol 15(1):116–124
Weiterführende Literatur
Deutsches Ärzteblatt 116; Heft 23-24; 10.06.2019; C 966-967
Nationale VersorgungsLeitlinie Nierenerkrankungen bei Diabetes im Erwachsenenalter, 1. Aufl., Version 5, 2010, letzte Änderung Mai 2013, AWMF-Registernummer: nvl-001d
NVL (Nationale VersorgungsLeitlinie) Therapie des Typ-2-Diabetes, 1. Aufl., Version 3, August 2013, letzte Änderung April 2014, AWMF-Registernummer: nvl-001g
S2k-Leitlinie Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Alter der Deutschen Diabetes Gesellschaft (DDG), 2. Aufl., 2018, AWMF-Registernummer: 057-017
PatientenLeitlinie zur Nationalen VersorgungsLeitlinie „Typ-2-Diabetes Prävention und Behandlungsstrategien für Fußkomplikationen“, Version 01.01, 2008
PatientenLeitlinie zur Nationalen VersorgungsLeitlinie „Neuropathie bei Diabetes im Erwachsenenalter“, 1. Aufl., Version 1.0, 2014
PatientenLeitlinie zur Nationalen VersorgungsLeitlinie „Therapie des Typ-2-Diabetes“, 1. Aufl., Version 1, Juni 2015
PatientenLeitlinie zur Nationalen VersorgungsLeitlinie „Diabetes Schäden an der Netzhaut: vorbeugen und behandeln“, 2. Aufl., Version 2, 2016
Zeyfang A et al (2017) Diabetes mellitus im Alter. Diabetologie 12(Suppl 2):203–211
Ziegler D et al (2017) Diabetische Neuropathie. Diabetologie 12(Suppl 2):101–114
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Hardt, R., Seibert-Grafe, M., Fellgiebel, A., Wiechelt, J., Schulz, G., Thomczyk, S. (2019). Prävention im Alter – Was ist gesichert?. In: Hardt, R., Junginger, T., Seibert-Grafe, M. (eds) Prävention im Alter – Gesund und fit älter werden. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-56788-3_2
Download citation
DOI: https://doi.org/10.1007/978-3-662-56788-3_2
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-56787-6
Online ISBN: 978-3-662-56788-3
eBook Packages: Medicine (German Language)